It is rare to do actual drug research on pregnant patients so it is always a boon when good research comes out that relates to pregnancy. Glaxo-SmithKline has a drug registry that has tracked pregnant women taking sumatriptan ornaratriptan since 1996. They have collected information on over 800 pregnancies and found that neither drug causes an increase in birth defects compared to migraine sufferers generally.
As of right now, all triptan medications are considered Pregnancy Class C, meaning not enough data is available to make a definitive statement on their safety. Potential risks should be weighed against the possible benefits of the medicine. Hopefully this data can lead to more clear evidence on the safety of triptans in pregnancy. As with all headache treatments, be sure to discuss them with your primary care or other health care provider.
Read more about treating headaches in pregnancy.
Looking for natural headache cures during pregnancy?
=============================
To keep up on useful information
related to headaches and migraines,
subscribe to the
Headaches and Migraines Newsletter.
=============================
